Epistem Announces Partnership with The University of Manchester
Epistem plc announce a partnership with Dr Matthew Hardman at The University of Manchester in which novel preclinical models for cutaneous wound healing, developed within Dr Hardman’s laboratory, will be transferred to Epistem.
Epistem and The University of Manchester have been awarded a Knowledge Transfer Partnership (KTP) grant from the Technology Strategy Board and Medical Research Council to optimise, validate and commercialise new preclinical assays for wound repair. A KTP Associate has been appointed to work within Epistem on the project. Dr Hardman is a world-leading expert in molecular and cellular aspects of pathological healing and heads a multi-disciplinary research group within the Manchester Healing Foundation Centre for Tissue Regeneration at the University. Epistem’s Contract Research Services Division provides specialised preclinical and scientific research services to drug development and personal care companies in the areas of oncology, mucositis, inflammatory bowel disease, wound healing and skincare. Epistem are experienced in commercialising new technologies and the partnership will allow the Company to expand its existing range of wound healing models and to provide a broad, innovative service range.
Other news from the department science

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
Ventana announces collaboration to develop companion diagnostics for ImmunoGen's targeted anticancer agents
High-Tech Gründerfonds, Bayern Kapital and BioM AG to invest in Intana Bioscience GmbH

Heart hormone helps shape fat metabolism - Sanford-Burnham study shows that the pathway to losing fat is heavily influenced by a hormone produced in the heart
Low-carb diets linked to atherosclerosis and impaired blood vessel growth - Study suggests that popular diet regimen may have adverse effect on body's restorative capacity

Autoimmunity: immune cells escape therapy due to "exhausted" state - Researchers have succeeded in isolating and analyzing disease-causing T cells from the blood in autoimmune diseases
Fluidity Predicts Aggressiveness of Cancerous Tumours
Biogemma and Wageningen UR announce a collaboration in wheat drought tolerance research
Harvard Apparatus Acquires PanLab s.l. - A New Acquisition by Harvard Apparatus Expands its Behavioral Sciences Product Offerings

SCIO Automation Munich GmbH - Frankenthal, Germany

SRI Instruments Europe GmbH - Bad Honnef, Germany

PBK Buschmann - Mülheim (Ruhr), Germany
